Comparison of Ocular Characteristic Between Major Thalassemia and Healthy Group
暂无分享,去创建一个
H. Hashemi | S. Sardari | M. Khabazkhoob | R. Pakzad | A. Yekta | H. Ostadimoghaddam | L. Koochakzadeh | S. Heydarian | Fahimeh Khoshhal | P. Tajzadeh | Zahra Hemmatian Rabbani
[1] Beta Thalassemia , 2020, Definitions.
[2] H. Hashemi,et al. The distribution of near point of convergence in an Iranian rural population: A population-based cross-sectional study , 2019, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.
[3] E. Jafarzadehpour,et al. Comparison of contrast sensitivity in β-thalassemia patients treated by deferoxamine or deferasirox , 2018, Journal of optometry.
[4] A. A. El-Shazly,et al. Relation of anthropometric measurements to ocular biometric changes and refractive error in children with thalassemia , 2018, European journal of ophthalmology.
[5] H. Hashemi,et al. The prevalence of color vision deficiency in the northeast of Iran , 2017, Journal of current ophthalmology.
[6] A. Liaska,et al. β-Thalassemia and ocular implications: a systematic review , 2016, BMC Ophthalmology.
[7] R. Jafari,et al. Refractive errors and ocular biometry components in thalassemia major patients , 2016, International Ophthalmology.
[8] R. Jafari,et al. Ocular abnormalities in multi-transfused beta-thalassemia patients , 2015, Indian journal of ophthalmology.
[9] G. Ozdemir,et al. Ocular findings in children with thalassemia major in Eastern Mediterranean. , 2014, International journal of ophthalmology.
[10] M. Nowroozzadeh,et al. Ocular refractive and biometric characteristics in patients with thalassaemia major , 2011, Clinical & experimental optometry.
[11] F. Trachtenberg,et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America , 2009, British journal of haematology.
[12] F. Ghodsi,et al. ASSESSING THE REFRACTIVE ERRORS IN BETA-THALASSEMIA MAJOR PATIENTS , 2009 .
[13] M. Repanti,et al. Study of the eye and lacrimal glands in experimental iron overload in rats in vivo , 2008, Anatomical science international.
[14] M. Radfar,et al. Thalassemia in Iran: Epidemiology, Prevention, and Management , 2007, Journal of pediatric hematology/oncology.
[15] P. Perissutti,et al. Congenital Growth Hormone Deficiency and Eye Refraction: A Longitudinal Study , 2005, Ophthalmologica.
[16] E. Terpos,et al. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia , 2004, British journal of haematology.
[17] P. Perissutti,et al. Refractive evaluation in children with growth defect , 2004, Current eye research.
[18] S. Laradi,et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[19] S. Gartaganis,et al. Alterations in Conjunctival Cytology and Tear Film Dysfunction in Patients with &bgr;-Thalassemia , 2003, Cornea.
[20] M. Bekheirnia,et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran , 2003, BMC endocrine disorders.
[21] S. Schrier. Pathophysiology of the thalassemias. The Albion Walter Hewlett Award presentation. , 1997, The Western journal of medicine.
[22] H. Pearson,et al. PATHOPHYSIOLOGY OF THALASSEMIAS , 1974, Annals of the New York Academy of Sciences.
[23] M. Bandyopadhyay,et al. A Study to Assess the Ocular Biometric Parameters and Prevalence of Refractive Errors among Thalassemic Children in a Rural Based Tertiary Hospital , 2017 .
[24] K. Saad,et al. Growth Parameters and Vitamin D status in Children with Thalassemia Major in Upper Egypt , 2013, International journal of hematology-oncology and stem cell research.
[25] Pat Beckley. Historical Perspectives , 2006 .